Highlights•A bibliometric review of drug repurposing provides novel insights into the
practice.•Some drugs have been tried in hundreds of diseases.•Even an old drug like …

Cancer represents a significant global health and economic burden due to its high mortality
rates. While effective in some instances, traditional chemotherapy often falls short of entirely …

As the field of cancer neuroscience expands, the strategic targeting of interactions between
neurons, cancer cells and other elements in the tumour microenvironment represents a …

Repurposing is a drug development strategy that seeks to use existing medications for new
indications. In oncology, there is an increased level of activity looking at the use of non …

The relationship between psychosocial factors and cancer has intrigued people for
centuries. In the last several decades there has been an expansion of mechanistic research …

Silk has a robust clinical track record and is emerging as a promising biopolymer for drug
delivery, including its use as nanomedicine. However, silk-based nanomedicines still …

Vitamin D deficiency is linked to pathogenesis of many diseases including cardiovascular,
cancer, and various eye diseases. In recent years, important roles for vitamin D in regulation …

Discovery of new drugs for cancer treatment is an expensive and time-consuming process
and the percentage of drugs reaching the clinic remains quite low. Drug repositioning refers …

Lung cancer is a highly invasive and prevalent disease with ineffective first-line treatment
and remains the leading cause of cancer death in men and women. Despite the …

Repurposing the large arsenal of existing non‐cancer drugs is an attractive proposition to
expand the clinical pipelines for cancer therapeutics. The earlier successes in repurposing …